Skin Rashes Caused by the use of Latex Gloves in Hospitals Soon to Become a Thing of the Past

DUSSELDORF, Germany, November 18, 2010 - A new technology is set to reduce the allergic potential of latex gloves
to virtually zero. Developed by the Dutch company Budev, the patented MPXXTM
technology is used to wash latex during manufacture. The new process and the
Cleantexx brand gloves made with it will be introduced at the MEDICA trade
fair in Dusseldorf from 17-20 November 2010.

Cleantexx gloves are produced in Malaysia by Total Glove, a
Dutch-Malaysian joint venture between Budev and the Malaysian manufacturer
Latexx Partners.

"Our product aims to offer a lasting solution to the problem of allergies
caused by latex gloves. Efforts by manufacturers, legislators and users have
brought about in a drop in the number of statistically recorded cases of
contact dermatitis due to hypersensitivity to latex proteins, but they
haven't been able to eliminate the problem completely. Also latex allergy
Type IV is upcoming for nitrile gloves. That may be about to change," says
Michiel Paping, CEO of Budev and one of the Directors of Total Glove.

Budev has granted Total Glove the right to use its MPXX(TM)
technology in a licensing agreement for the manufacture of latex gloves. The
technology is used to wash the protein residue from the gloves as a final
step in the manufacturing process.

Current regulations require commercially available medical
gloves to guarantee a latex protein content of less that 50 microg/g. The
levels of the four allergenic proteins in gloves treated with the MPXX(TM)
process are so miniscule that they cannot be quantifiable by any of the
standard methods - such as the Lowry and FITKit tests prescribed in Europe
and in the US - or in even more stringent tests conducted by the dermatology
department at the university hospital in Erlangen, Germany. Thus MPXX(TM) not
only meets the current ASTM and EN 455 standards, it actually exceeds them by
far.

The joint venture is limited to using the new technology to
produce Cleantexx examination and surgical gloves, but Budev CEO Paping plans
to apply the new process to the manufacture of other products made of natural
rubber in the future.

Serial production of Cleantexx gloves has already begun in
Malaysia, and they are already for sale in Europe. The gloves are available
in two quality grades, and pricing is "fair and highly competitive,
considering the excellent value of the product," says Paping.

For more details, visit www.mpxx.org and
www.total-glove.com.

    Editorial:
    KaiserCommunication GmbH
    Florian Boenigk
    M: +49(0)30-726188435
    boenigk@kaisercommunication.de

    Contact:
    Total Glove Company Sdn Bhd
    (Malaysia)
    Karen-Marlies Schenck
    T: +6058915500
    info@total-glove.com

Editorial: KaiserCommunication GmbH, Florian Boenigk, M: +49(0)30-726188435, boenigk at kaisercommunication.de, Contact: Total Glove Company Sdn Bhd, (Malaysia), Karen-Marlies Schenck, T: +6058915500, info at total-glove.com